Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support
4 Articles
4 Articles
A recent scientific study has shown that a tuberculosis vaccine known as BCG may contribute to reducing some of the brain changes associated with dementia.
The team found that the genetically modified animals to present the symptoms of the disease and that they received the dose were less likely to have it.
Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support
Bacillus Calmette-Guerin (BCG), a vaccine widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia, according to new findings in a study of mice. BCG is a live, weakened vaccine made from an altered strain of the bacterium Mycobacterium bovis.
BCG Vaccine-Induced Trained Immunity May Help Protect Against Dementia
The results of a preclinical study suggest that the BCG vaccine, which is widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia by inducing trained immunity. The post BCG Vaccine-Induced Trained Immunity May Help Protect Against Dementia appeared first on GEN - Genetic Engineering and Biotechnology News.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
